Interestingly, calsyntenin-1 levels are reduced in Alzheimer’s disease brains and this suggests that calsyntenin-1 loss contributes to damaged APP transport in Alzheimer’s disease [56]. This evidence concerns the gene APP and Alzheimer disease.